Related Experiment Video
Updated: Jun 13, 2025
09:30
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
Published on: October 4, 2016
22.3K
Repetitive Transcranial Magnetic Stimulation (rTMS) in Major Depression
Vitor Breda1,2, Rafael Freire3,4,5
1Department of Psychiatry, Western University, London, ON, Canada.
Advances in Experimental Medicine and Biology
|September 11, 2024
Summary
Repetitive transcranial magnetic stimulation (rTMS) offers a non-drug, non-psychotherapy option for major depressive disorder (MDD). Evidence shows rTMS is effective and safe for treatment-resistant depression, despite ongoing research into optimal parameters.
Area of Science:
- Neuroscience
- Psychiatry
- Medical Technology
Background:
- Major depressive disorder (MDD) treatments like antidepressants and psychotherapy have limitations.
- Alternative therapies are needed due to side effects, efficacy issues, and contraindications.
- Neurostimulation, including repetitive transcranial magnetic stimulation (rTMS), is an emerging non-pharmacological approach.
Purpose of the Study:
- To review the efficacy, tolerability, and safety of rTMS for treatment-resistant depression.
- To highlight rTMS as an alternative to conventional MDD therapies.
- To discuss the evolving nature and challenges of rTMS technology and application.
Main Methods:
- Review of double-blind sham-controlled randomized controlled trials and meta-analyses.
- Focus on rTMS as a brain stimulation technique.
- Analysis of rTMS protocols and their impact on neuroplasticity.
Main Results:
- rTMS demonstrates efficacy, tolerability, and safety in treating major depressive disorder.
- Evidence supports rTMS, particularly for treatment-resistant cases.
- rTMS appears to exert beneficial effects by modulating neuroplasticity.
Conclusions:
- rTMS is a viable non-pharmacological treatment option for major depressive disorder.
- Further research is needed to refine rTMS parameters and address cost/accessibility.
- rTMS shows promise as a valuable tool in psychiatric treatment paradigms.
